Patient Confidentiality and Medication-Assisted Treatment in California Primary Care Settings
The second in a series of 12 monthly webinars designed to support the implementation of Medication Assisted Treatment (MAT) in primary care. As California's primary care (PC) clinics work to integrate medication-assisted treatment (MAT) into services, they will encounter questions around legal regulations governing privacy of patient records. What is 42 CFR Part 2? What does it mean & how does it apply to PC? Can certain PC program design elements allow unified medical charting by not activating this regulation? How can you recruit patients w/out “putting yourself out?” This webinar is an introduction to these issues (without giving any formal legal advice).
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.
- Primary Care Physician who are beginning or planning to integrate buprenorphine for the treatment of opioid dependence into theit practice.
- Associated health professionals who work in a setting that treats opioid dependent patients.
David Kan, MD
UCSF Clinical Faculty, Private Practice, Medical Director, Addiction Treatment Unit, Bright Heart Health
Harry Nelson, JD
Managing Partner, Nelson, Hardiman LLP
Dr. Kan, Mr. Nelson and the planning group for this workshop have no relevant financial relationships to disclose.
- 1.00 Attendance
- 1.00 AMA Category 1
- Recognize the 2 elements of a program that need to be present to activate 42 CFR Part 2 (Federal laws regulating confidentiality of medical records of substance use diagnosis & treatment);
- Implement program design elements of MAT services in PC to address legal issues of patient confidentiality;
- Apply legal rules to address patient confidenialoity;
- Understand when they can release patient medical records without written consent in the case of a medical emergency or suspected child abuse if they work in a program that activates 42 CFR part 2.